BGM Stock Analysis: Buy, Sell, or Hold?
BGM - BGM Group Ltd. Class A Ordinary Shares
$0.36
0.02 (5.15%)
β²
5d:
-19.03%
30d:
+23.15%
90d:
-34.15%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Mar 10, 2026
0d
Get Alerted When BGM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: BGM is down 19.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: BGM is down 19.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BGM is currently trading at $0.36, which is considered fair relative to its 30-day fair value range of $0.29 to $0.38.
Technical Outlook: Technically, BGM is in a downtrend. Immediate support is located at $0.32, while resistance sits at $0.50. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: BGM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BGM is in a downtrend. Immediate support is located at $0.32, while resistance sits at $0.50. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: BGM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.29 -
$0.38
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
91.2%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.1%)
- WARNING: Recommendation downgraded due to -19.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.29 -
$0.38
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.32
Resistance Level
$0.50
Current Trend
Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Revenue Growth (YoY)
13.9%
Share & Embed Analysis
Last updated: June 24, 2026 12:52 PM ET
Data refreshes hourly during market hours. Next update: 1:52 PM
Data refreshes hourly during market hours. Next update: 1:52 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BGM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I⦠|
STRONG BUY
25 analysts |
$194 | 60 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 64 BUY |
|
BCRX
BioCryst Pharmaceuticals⦠|
STRONG BUY
12 analysts |
$21 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 58 HOLD |
|
UTHR
United Therapeutics Corp⦠|
STRONG BUY
15 analysts |
$665 | 57 HOLD |